Dalrada Financial Corp (DFCO): The "pharmacy division" has no unique pr...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	481
Posts	60441
Boards Moderated	18
Alias Born	09/20/2001

XenaLives

Re: batty boots post# 26223

Tuesday, 04/23/2024 10:51:39 AM

Tuesday, April 23, 2024 10:51:39 AM

The "pharmacy division" has no unique product, no IP, nothing......

Just like all of the other DFCO "divisions"

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent DFCO News

Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 07:39:08 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 01:18:05 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 10:19:36 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 11:25:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 02:51:49 AM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/19/2023 07:57:47 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/12/2023 09:06:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 12:01:32 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/29/2023 11:53:53 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/22/2023 09:23:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2023 06:45:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:15:35 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 08:13:57 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/13/2023 11:59:05 AM

More DFCO News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover